|
|
Attovia Therapeutics Inc
NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/18/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,101.34 mln
Float26.26 mln
Earnings Date11/11/2026
1-Year Forecast
42.20
Transformational upside
Relative Strength
10
/ 100
Significantly lagging
Pre-Tax Margin
-4,491%
Severely loss-making
Key Fundamentals
EPS-1.64
RPS0.44
ROIC-629
ROA-49.98
EBITDA, mln-66.36
EV / EBITDA-11.50
EV / EBIT-11.36
Revenue, mln1.35
EV / Revenue565
Financial Strength
1-Year Target Price42.20
Short Ratio0.54
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-2.85% |
20
/ 100
 |
| 1 Month |
0% |
74
/ 100
 |
|
| |
